ATRC - AtriCure, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

AtriCure, Inc.

7555 Innovation Way
Mason, OH 45040
United States
513-755-4100
http://www.atricure.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees620

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael H. CarrelCEO, Pres & Director1.56MN/A1971
Mr. M. Andrew Wade CPASr. VP & CFO700.8kN/A1975
Mr. Douglas J. SeithChief Operating Officer944.01kN/A1966
Mr. Salvatore Privitera J.D.Chief Technical Officer620.85kN/A1967
Mr. Justin J. NozneskySr. VP of Marketing & Bus. Devel.610.71kN/A1978
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures; EPi-Sense guided coagulation system used for the coagulation of tissue; and COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy. It also provides multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable users to make longer linear lines of ablation. In addition, the company offers cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias; AtriClip system used to occlude the left atrial appendage by mechanically clamping the appendage; and CryoICE CRYO2 cryoablation system to apply cryo-energy to targeted intercostal peripheral nerves in the ribcage and temporarily relieve pain. Further, it provides Lumitip dissector to separate tissues to provide access to key anatomical structures that are targeted for ablation; Fusion Magnetic Retriever System that allows access around anatomical structures; and cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. The company sells its products through independent distributors and direct sales personnel. The company was founded in 2000 and is headquartered in Mason, Ohio.

Corporate Governance

AtriCure, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 3. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 3; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.